Emergent BioSolutions Gets $60m in Smallpox Contracts

March 25, 2026, 8:22 PM UTC

Emergent BioSolutions secured an about $54m contract to deliver CNJ-016 to the US HHS under its Administration for Strategic Preparedness and Response agency.

  • Additional $6.6 million in orders from international government for ACAM2000 vaccine

To view the source of this information, click here

To contact the reporter on this story:
Cameron Baker in Boston at cbaker225@bloomberg.net

To contact the editor responsible for this story:
Ilya Banares at ibanares@bloomberg.net

© 2026 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.